Altria Group is set to announce its second-quarter earnings later this month, and Wall Street expects a single-digit rise in its profits.
1 S&P 500 Stock with Competitive Advantages and 2 We Find Risky
Philip Morris International ($PM) said the U.S. Food and Drug Administration has authorized 20 variants of its Zyn nicotine pouches to be marketed as posing a lower health risk than cigarettes. The authorization...
2 Value Stocks with Solid Fundamentals and 1 We Turn Down
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges
Altria, Enterprise Products Partners, and NNN REIT offer dividend yields near 5% to 6%, multi-year dividend growth streaks, and bullish technical setups.
Altria and Philip Morris may look similar, but their dividends, markets, valuations, and smoke-free strategies tell a very different story.
Altria Group has underperformed the Dow Jones over the past year, and analysts remain moderately optimistic about the stock’s outlook.
